0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Avian Influenza Vaccines Market Research Report 2026
Published Date: 2026-02-03
|
Report Code: QYRE-Auto-11161
Home | Market Reports
Global Avian Influenza Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Global Avian Influenza Vaccines Market Research Report 2026

Code: QYRE-Auto-11161
Report
2026-02-03
Pages:145
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Avian Influenza Vaccines Market Size

The global Avian Influenza Vaccines market was valued at US$ 1154 million in 2025 and is anticipated to reach US$ 1671 million by 2032, at a CAGR of 5.5% from 2026 to 2032.

Avian Influenza Vaccines Market

Avian Influenza Vaccines Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Avian Influenza Vaccines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.
The avian influenza vaccines market is driven by the increasing prevalence of avian flu outbreaks, which pose significant threats to both poultry industries and public health. As global poultry consumption rises, the need to protect livestock from highly pathogenic avian influenza strains is critical to maintaining food security and preventing economic losses. Governments and regulatory bodies are increasingly focused on preventing zoonotic transmission, leading to the widespread use of vaccines in poultry farms. Additionally, ongoing advancements in vaccine development, such as more effective and faster-acting vaccines, are further driving market growth.
A major challenge in the avian influenza vaccines market is the high cost and logistical difficulties of mass vaccination programs, especially in large-scale poultry farms or regions with limited veterinary infrastructure. The need for continuous monitoring and re-vaccination due to the evolving nature of avian influenza strains adds to the complexity and cost of vaccine deployment. Additionally, regulatory barriers and varying standards for vaccine approval across different countries can hinder the global distribution of vaccines, limiting market expansion in certain regions.
Global Avian Influenza Vaccines key players include Boehringer Ingelheim, CAHIC, DHN, HVRI, etc. Global top five manufacturers hold a share over 70%. China is the largest market, with a share about 45%. In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.
This report delivers a comprehensive overview of the global Avian Influenza Vaccines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Avian Influenza Vaccines. The Avian Influenza Vaccines market size, estimates, and forecasts are provided in terms of sales volume (M Doses) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Avian Influenza Vaccines market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Avian Influenza Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Avian Influenza Vaccines Market Report

Report Metric Details
Report Name Avian Influenza Vaccines Market
Accounted market size in 2025 US$ 1154 million
Forecasted market size in 2032 US$ 1671 million
CAGR 5.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • H5+H7 Avian Influenza Vaccines
  • H9 Avian Influenza Vaccines
by Application
  • Chicken
  • Duck & Goose
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, CAHIC, DHN, HVRI, CEVA, Elanco Animal Health, Zoetis, FATRO, Kyoto Biken, CAVAC, Ringpu Biology, Vaksindo, Sindh Poultry Vaccine Centre, Merck Animal Health, PT Medion Farma Jaya, Avimex Animal Health, JOVAC, Bio-Labs, Pusvetma, IPB-Shigeta, Medion Farma Jaya, Caprifamarindo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Avian Influenza Vaccines manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Avian Influenza Vaccines sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Avian Influenza Vaccines Market growing?

Ans: The Avian Influenza Vaccines Market witnessing a CAGR of 5.5% during the forecast period 2026-2032.

What is the Avian Influenza Vaccines Market size in 2032?

Ans: The Avian Influenza Vaccines Market size in 2032 will be US$ 1671 million.

What is the market share of major companies in Avian Influenza Vaccines Market?

Ans: Global top five manufacturers hold a share over 70%.

What is the Avian Influenza Vaccines Market share by region?

Ans: China is the largest market, with a share about 45%.

Who are the main players in the Avian Influenza Vaccines Market report?

Ans: The main players in the Avian Influenza Vaccines Market are Boehringer Ingelheim, CAHIC, DHN, HVRI, CEVA, Elanco Animal Health, Zoetis, FATRO, Kyoto Biken, CAVAC, Ringpu Biology, Vaksindo, Sindh Poultry Vaccine Centre, Merck Animal Health, PT Medion Farma Jaya, Avimex Animal Health, JOVAC, Bio-Labs, Pusvetma, IPB-Shigeta, Medion Farma Jaya, Caprifamarindo

What are the Application segmentation covered in the Avian Influenza Vaccines Market report?

Ans: The Applications covered in the Avian Influenza Vaccines Market report are Chicken, Duck & Goose, Other

What are the Type segmentation covered in the Avian Influenza Vaccines Market report?

Ans: The Types covered in the Avian Influenza Vaccines Market report are H5+H7 Avian Influenza Vaccines, H9 Avian Influenza Vaccines

1 Avian Influenza Vaccines Market Overview
1.1 Product Definition
1.2 Avian Influenza Vaccines by Type
1.2.1 Global Avian Influenza Vaccines Market Value by Type: 2025 vs 2032
1.2.2 H5+H7 Avian Influenza Vaccines
1.2.3 H9 Avian Influenza Vaccines
1.3 Avian Influenza Vaccines by Application
1.3.1 Global Avian Influenza Vaccines Market Value by Application: 2025 vs 2032
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Global Avian Influenza Vaccines Market Size Estimates and Forecasts
1.4.1 Global Avian Influenza Vaccines Revenue 2021–2032
1.4.2 Global Avian Influenza Vaccines Sales 2021–2032
1.4.3 Global Avian Influenza Vaccines Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Avian Influenza Vaccines Market Competition by Manufacturers
2.1 Global Avian Influenza Vaccines Sales Market Share by Manufacturers (2021–2026)
2.2 Global Avian Influenza Vaccines Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Avian Influenza Vaccines Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Avian Influenza Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Avian Influenza Vaccines, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Avian Influenza Vaccines, Product Types and Applications
2.7 Global Key Manufacturers of Avian Influenza Vaccines, Date of Entry into the Industry
2.8 Global Avian Influenza Vaccines Market Competitive Situation and Trends
2.8.1 Global Avian Influenza Vaccines Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Avian Influenza Vaccines Players Market Share by Revenue
2.8.3 Global Avian Influenza Vaccines Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Avian Influenza Vaccines Market Scenario by Region
3.1 Global Avian Influenza Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Avian Influenza Vaccines Sales by Region: 2021–2032
3.2.1 Global Avian Influenza Vaccines Sales by Region: 2021–2026
3.2.2 Global Avian Influenza Vaccines Sales by Region: 2027–2032
3.3 Global Avian Influenza Vaccines Revenue by Region: 2021–2032
3.3.1 Global Avian Influenza Vaccines Revenue by Region: 2021–2026
3.3.2 Global Avian Influenza Vaccines Revenue by Region: 2027–2032
3.4 North America Avian Influenza Vaccines Market Facts & Figures by Country
3.4.1 North America Avian Influenza Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Avian Influenza Vaccines Sales by Country (2021–2032)
3.4.3 North America Avian Influenza Vaccines Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Avian Influenza Vaccines Market Facts & Figures by Country
3.5.1 Europe Avian Influenza Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Avian Influenza Vaccines Sales by Country (2021–2032)
3.5.3 Europe Avian Influenza Vaccines Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Avian Influenza Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Avian Influenza Vaccines Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Avian Influenza Vaccines Sales by Region (2021–2032)
3.6.3 Asia Pacific Avian Influenza Vaccines Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Avian Influenza Vaccines Market Facts & Figures by Country
3.7.1 Latin America Avian Influenza Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Avian Influenza Vaccines Sales by Country (2021–2032)
3.7.3 Latin America Avian Influenza Vaccines Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Avian Influenza Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Avian Influenza Vaccines Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Avian Influenza Vaccines Sales by Country (2021–2032)
3.8.3 Middle East and Africa Avian Influenza Vaccines Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Avian Influenza Vaccines Sales by Type (2021–2032)
4.1.1 Global Avian Influenza Vaccines Sales by Type (2021–2026)
4.1.2 Global Avian Influenza Vaccines Sales by Type (2027–2032)
4.1.3 Global Avian Influenza Vaccines Sales Market Share by Type (2021–2032)
4.2 Global Avian Influenza Vaccines Revenue by Type (2021–2032)
4.2.1 Global Avian Influenza Vaccines Revenue by Type (2021–2026)
4.2.2 Global Avian Influenza Vaccines Revenue by Type (2027–2032)
4.2.3 Global Avian Influenza Vaccines Revenue Market Share by Type (2021–2032)
4.3 Global Avian Influenza Vaccines Price by Type (2021–2032)
5 Segment by Application
5.1 Global Avian Influenza Vaccines Sales by Application (2021–2032)
5.1.1 Global Avian Influenza Vaccines Sales by Application (2021–2026)
5.1.2 Global Avian Influenza Vaccines Sales by Application (2027–2032)
5.1.3 Global Avian Influenza Vaccines Sales Market Share by Application (2021–2032)
5.2 Global Avian Influenza Vaccines Revenue by Application (2021–2032)
5.2.1 Global Avian Influenza Vaccines Revenue by Application (2021–2026)
5.2.2 Global Avian Influenza Vaccines Revenue by Application (2027–2032)
5.2.3 Global Avian Influenza Vaccines Revenue Market Share by Application (2021–2032)
5.3 Global Avian Influenza Vaccines Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Company Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Boehringer Ingelheim Avian Influenza Vaccines Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 CAHIC
6.2.1 CAHIC Company Information
6.2.2 CAHIC Description and Business Overview
6.2.3 CAHIC Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 CAHIC Avian Influenza Vaccines Product Portfolio
6.2.5 CAHIC Recent Developments/Updates
6.3 DHN
6.3.1 DHN Company Information
6.3.2 DHN Description and Business Overview
6.3.3 DHN Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 DHN Avian Influenza Vaccines Product Portfolio
6.3.5 DHN Recent Developments/Updates
6.4 HVRI
6.4.1 HVRI Company Information
6.4.2 HVRI Description and Business Overview
6.4.3 HVRI Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 HVRI Avian Influenza Vaccines Product Portfolio
6.4.5 HVRI Recent Developments/Updates
6.5 CEVA
6.5.1 CEVA Company Information
6.5.2 CEVA Description and Business Overview
6.5.3 CEVA Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 CEVA Avian Influenza Vaccines Product Portfolio
6.5.5 CEVA Recent Developments/Updates
6.6 Elanco Animal Health
6.6.1 Elanco Animal Health Company Information
6.6.2 Elanco Animal Health Description and Business Overview
6.6.3 Elanco Animal Health Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Elanco Animal Health Avian Influenza Vaccines Product Portfolio
6.6.5 Elanco Animal Health Recent Developments/Updates
6.7 Zoetis
6.7.1 Zoetis Company Information
6.7.2 Zoetis Description and Business Overview
6.7.3 Zoetis Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Zoetis Avian Influenza Vaccines Product Portfolio
6.7.5 Zoetis Recent Developments/Updates
6.8 FATRO
6.8.1 FATRO Company Information
6.8.2 FATRO Description and Business Overview
6.8.3 FATRO Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 FATRO Avian Influenza Vaccines Product Portfolio
6.8.5 FATRO Recent Developments/Updates
6.9 Kyoto Biken
6.9.1 Kyoto Biken Company Information
6.9.2 Kyoto Biken Description and Business Overview
6.9.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Kyoto Biken Avian Influenza Vaccines Product Portfolio
6.9.5 Kyoto Biken Recent Developments/Updates
6.10 CAVAC
6.10.1 CAVAC Company Information
6.10.2 CAVAC Description and Business Overview
6.10.3 CAVAC Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 CAVAC Avian Influenza Vaccines Product Portfolio
6.10.5 CAVAC Recent Developments/Updates
6.11 Ringpu Biology
6.11.1 Ringpu Biology Company Information
6.11.2 Ringpu Biology Description and Business Overview
6.11.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Ringpu Biology Avian Influenza Vaccines Product Portfolio
6.11.5 Ringpu Biology Recent Developments/Updates
6.12 Vaksindo
6.12.1 Vaksindo Company Information
6.12.2 Vaksindo Description and Business Overview
6.12.3 Vaksindo Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Vaksindo Avian Influenza Vaccines Product Portfolio
6.12.5 Vaksindo Recent Developments/Updates
6.13 Sindh Poultry Vaccine Centre
6.13.1 Sindh Poultry Vaccine Centre Company Information
6.13.2 Sindh Poultry Vaccine Centre Description and Business Overview
6.13.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolio
6.13.5 Sindh Poultry Vaccine Centre Recent Developments/Updates
6.14 Merck Animal Health
6.14.1 Merck Animal Health Company Information
6.14.2 Merck Animal Health Description and Business Overview
6.14.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Merck Animal Health Avian Influenza Vaccines Product Portfolio
6.14.5 Merck Animal Health Recent Developments/Updates
6.15 PT Medion Farma Jaya
6.15.1 PT Medion Farma Jaya Company Information
6.15.2 PT Medion Farma Jaya Description and Business Overview
6.15.3 PT Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 PT Medion Farma Jaya Avian Influenza Vaccines Product Portfolio
6.15.5 PT Medion Farma Jaya Recent Developments/Updates
6.16 Avimex Animal Health
6.16.1 Avimex Animal Health Company Information
6.16.2 Avimex Animal Health Description and Business Overview
6.16.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Avimex Animal Health Avian Influenza Vaccines Product Portfolio
6.16.5 Avimex Animal Health Recent Developments/Updates
6.17 JOVAC
6.17.1 JOVAC Company Information
6.17.2 JOVAC Description and Business Overview
6.17.3 JOVAC Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 JOVAC Avian Influenza Vaccines Product Portfolio
6.17.5 JOVAC Recent Developments/Updates
6.18 Bio-Labs
6.18.1 Bio-Labs Company Information
6.18.2 Bio-Labs Description and Business Overview
6.18.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Bio-Labs Avian Influenza Vaccines Product Portfolio
6.18.5 Bio-Labs Recent Developments/Updates
6.19 Pusvetma
6.19.1 Pusvetma Company Information
6.19.2 Pusvetma Description and Business Overview
6.19.3 Pusvetma Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Pusvetma Avian Influenza Vaccines Product Portfolio
6.19.5 Pusvetma Recent Developments/Updates
6.20 IPB-Shigeta
6.20.1 IPB-Shigeta Company Information
6.20.2 IPB-Shigeta Description and Business Overview
6.20.3 IPB-Shigeta Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 IPB-Shigeta Avian Influenza Vaccines Product Portfolio
6.20.5 IPB-Shigeta Recent Developments/Updates
6.21 Medion Farma Jaya
6.21.1 Medion Farma Jaya Company Information
6.21.2 Medion Farma Jaya Description and Business Overview
6.21.3 Medion Farma Jaya Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Medion Farma Jaya Avian Influenza Vaccines Product Portfolio
6.21.5 Medion Farma Jaya Recent Developments/Updates
6.22 Caprifamarindo
6.22.1 Caprifamarindo Company Information
6.22.2 Caprifamarindo Description and Business Overview
6.22.3 Caprifamarindo Avian Influenza Vaccines Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Caprifamarindo Avian Influenza Vaccines Product Portfolio
6.22.5 Caprifamarindo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Avian Influenza Vaccines Industry Chain Analysis
7.2 Avian Influenza Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Avian Influenza Vaccines Production Mode & Process Analysis
7.4 Avian Influenza Vaccines Sales and Marketing
7.4.1 Avian Influenza Vaccines Sales Channels
7.4.2 Avian Influenza Vaccines Distributors
7.5 Avian Influenza Vaccines Customer Analysis
8 Avian Influenza Vaccines Market Dynamics
8.1 Avian Influenza Vaccines Industry Trends
8.2 Avian Influenza Vaccines Market Drivers
8.3 Avian Influenza Vaccines Market Challenges
8.4 Avian Influenza Vaccines Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Avian Influenza Vaccines Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Avian Influenza Vaccines Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Avian Influenza Vaccines Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Avian Influenza Vaccines Sales (M Doses) of Key Manufacturers (2021–2026)
 Table 5. Global Avian Influenza Vaccines Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Avian Influenza Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Avian Influenza Vaccines Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Avian Influenza Vaccines Average Price (USD/K Doses) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Avian Influenza Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Avian Influenza Vaccines, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Avian Influenza Vaccines, Product Types and Applications
 Table 12. Global Key Manufacturers of Avian Influenza Vaccines, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Avian Influenza Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Avian Influenza Vaccines Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Avian Influenza Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Avian Influenza Vaccines Sales by Region (M Doses), 2021–2026
 Table 18. Global Avian Influenza Vaccines Sales Market Share by Region (2021–2026)
 Table 19. Global Avian Influenza Vaccines Sales by Region (M Doses), 2027–2032
 Table 20. Global Avian Influenza Vaccines Sales Market Share by Region (2027–2032)
 Table 21. Global Avian Influenza Vaccines Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Avian Influenza Vaccines Revenue Market Share by Region (2021–2026)
 Table 23. Global Avian Influenza Vaccines Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Avian Influenza Vaccines Revenue Market Share by Region (2027–2032)
 Table 25. North America Avian Influenza Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Avian Influenza Vaccines Sales by Country (M Doses), 2021–2026
 Table 27. North America Avian Influenza Vaccines Sales by Country (M Doses), 2027–2032
 Table 28. North America Avian Influenza Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Avian Influenza Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Avian Influenza Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Avian Influenza Vaccines Sales by Country (M Doses), 2021–2026
 Table 32. Europe Avian Influenza Vaccines Sales by Country (M Doses), 2027–2032
 Table 33. Europe Avian Influenza Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Avian Influenza Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Avian Influenza Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Avian Influenza Vaccines Sales by Region (M Doses), 2021–2026
 Table 37. Asia Pacific Avian Influenza Vaccines Sales by Region (M Doses), 2027–2032
 Table 38. Asia Pacific Avian Influenza Vaccines Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Avian Influenza Vaccines Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Avian Influenza Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Avian Influenza Vaccines Sales by Country (M Doses), 2021–2026
 Table 42. Latin America Avian Influenza Vaccines Sales by Country (M Doses), 2027–2032
 Table 43. Latin America Avian Influenza Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Avian Influenza Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Avian Influenza Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Avian Influenza Vaccines Sales by Country (M Doses), 2021–2026
 Table 47. Middle East and Africa Avian Influenza Vaccines Sales by Country (M Doses), 2027–2032
 Table 48. Middle East and Africa Avian Influenza Vaccines Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Avian Influenza Vaccines Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Avian Influenza Vaccines Sales (M Doses) by Type (2021–2026)
 Table 51. Global Avian Influenza Vaccines Sales (M Doses) by Type (2027–2032)
 Table 52. Global Avian Influenza Vaccines Sales Market Share by Type (2021–2026)
 Table 53. Global Avian Influenza Vaccines Sales Market Share by Type (2027–2032)
 Table 54. Global Avian Influenza Vaccines Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Avian Influenza Vaccines Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Avian Influenza Vaccines Revenue Market Share by Type (2021–2026)
 Table 57. Global Avian Influenza Vaccines Revenue Market Share by Type (2027–2032)
 Table 58. Global Avian Influenza Vaccines Price (USD/K Doses) by Type (2021–2026)
 Table 59. Global Avian Influenza Vaccines Price (USD/K Doses) by Type (2027–2032)
 Table 60. Global Avian Influenza Vaccines Sales (M Doses) by Application (2021–2026)
 Table 61. Global Avian Influenza Vaccines Sales (M Doses) by Application (2027–2032)
 Table 62. Global Avian Influenza Vaccines Sales Market Share by Application (2021–2026)
 Table 63. Global Avian Influenza Vaccines Sales Market Share by Application (2027–2032)
 Table 64. Global Avian Influenza Vaccines Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Avian Influenza Vaccines Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Avian Influenza Vaccines Revenue Market Share by Application (2021–2026)
 Table 67. Global Avian Influenza Vaccines Revenue Market Share by Application (2027–2032)
 Table 68. Global Avian Influenza Vaccines Price (USD/K Doses) by Application (2021–2026)
 Table 69. Global Avian Influenza Vaccines Price (USD/K Doses) by Application (2027–2032)
 Table 70. Boehringer Ingelheim Company Information
 Table 71. Boehringer Ingelheim Description and Business Overview
 Table 72. Boehringer Ingelheim Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 73. Boehringer Ingelheim Avian Influenza Vaccines Product
 Table 74. Boehringer Ingelheim Recent Developments/Updates
 Table 75. CAHIC Company Information
 Table 76. CAHIC Description and Business Overview
 Table 77. CAHIC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 78. CAHIC Avian Influenza Vaccines Product
 Table 79. CAHIC Recent Developments/Updates
 Table 80. DHN Company Information
 Table 81. DHN Description and Business Overview
 Table 82. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 83. DHN Avian Influenza Vaccines Product
 Table 84. DHN Recent Developments/Updates
 Table 85. HVRI Company Information
 Table 86. HVRI Description and Business Overview
 Table 87. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 88. HVRI Avian Influenza Vaccines Product
 Table 89. HVRI Recent Developments/Updates
 Table 90. CEVA Company Information
 Table 91. CEVA Description and Business Overview
 Table 92. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 93. CEVA Avian Influenza Vaccines Product
 Table 94. CEVA Recent Developments/Updates
 Table 95. Elanco Animal Health Company Information
 Table 96. Elanco Animal Health Description and Business Overview
 Table 97. Elanco Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 98. Elanco Animal Health Avian Influenza Vaccines Product
 Table 99. Elanco Animal Health Recent Developments/Updates
 Table 100. Zoetis Company Information
 Table 101. Zoetis Description and Business Overview
 Table 102. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 103. Zoetis Avian Influenza Vaccines Product
 Table 104. Zoetis Recent Developments/Updates
 Table 105. FATRO Company Information
 Table 106. FATRO Description and Business Overview
 Table 107. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 108. FATRO Avian Influenza Vaccines Product
 Table 109. FATRO Recent Developments/Updates
 Table 110. Kyoto Biken Company Information
 Table 111. Kyoto Biken Description and Business Overview
 Table 112. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 113. Kyoto Biken Avian Influenza Vaccines Product
 Table 114. Kyoto Biken Recent Developments/Updates
 Table 115. CAVAC Company Information
 Table 116. CAVAC Description and Business Overview
 Table 117. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 118. CAVAC Avian Influenza Vaccines Product
 Table 119. CAVAC Recent Developments/Updates
 Table 120. Ringpu Biology Company Information
 Table 121. Ringpu Biology Description and Business Overview
 Table 122. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 123. Ringpu Biology Avian Influenza Vaccines Product
 Table 124. Ringpu Biology Recent Developments/Updates
 Table 125. Vaksindo Company Information
 Table 126. Vaksindo Description and Business Overview
 Table 127. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 128. Vaksindo Avian Influenza Vaccines Product
 Table 129. Vaksindo Recent Developments/Updates
 Table 130. Sindh Poultry Vaccine Centre Company Information
 Table 131. Sindh Poultry Vaccine Centre Description and Business Overview
 Table 132. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 133. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product
 Table 134. Sindh Poultry Vaccine Centre Recent Developments/Updates
 Table 135. Merck Animal Health Company Information
 Table 136. Merck Animal Health Description and Business Overview
 Table 137. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 138. Merck Animal Health Avian Influenza Vaccines Product
 Table 139. Merck Animal Health Recent Developments/Updates
 Table 140. PT Medion Farma Jaya Company Information
 Table 141. PT Medion Farma Jaya Description and Business Overview
 Table 142. PT Medion Farma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 143. PT Medion Farma Jaya Avian Influenza Vaccines Product
 Table 144. PT Medion Farma Jaya Recent Developments/Updates
 Table 145. Avimex Animal Health Company Information
 Table 146. Avimex Animal Health Description and Business Overview
 Table 147. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 148. Avimex Animal Health Avian Influenza Vaccines Product
 Table 149. Avimex Animal Health Recent Developments/Updates
 Table 150. JOVAC Company Information
 Table 151. JOVAC Description and Business Overview
 Table 152. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 153. JOVAC Avian Influenza Vaccines Product
 Table 154. JOVAC Recent Developments/Updates
 Table 155. Bio-Labs Company Information
 Table 156. Bio-Labs Description and Business Overview
 Table 157. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 158. Bio-Labs Avian Influenza Vaccines Product
 Table 159. Bio-Labs Recent Developments/Updates
 Table 160. Pusvetma Company Information
 Table 161. Pusvetma Description and Business Overview
 Table 162. Pusvetma Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 163. Pusvetma Avian Influenza Vaccines Product
 Table 164. Pusvetma Recent Developments/Updates
 Table 165. IPB-Shigeta Company Information
 Table 166. IPB-Shigeta Description and Business Overview
 Table 167. IPB-Shigeta Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 168. IPB-Shigeta Avian Influenza Vaccines Product
 Table 169. IPB-Shigeta Recent Developments/Updates
 Table 170. Medion Farma Jaya Company Information
 Table 171. Medion Farma Jaya Description and Business Overview
 Table 172. Medion Farma Jaya Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 173. Medion Farma Jaya Avian Influenza Vaccines Product
 Table 174. Medion Farma Jaya Recent Developments/Updates
 Table 175. Caprifamarindo Company Information
 Table 176. Caprifamarindo Description and Business Overview
 Table 177. Caprifamarindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses), and Gross Margin (2021–2026)
 Table 178. Caprifamarindo Avian Influenza Vaccines Product
 Table 179. Caprifamarindo Recent Developments/Updates
 Table 180. Key Raw Materials Lists
 Table 181. Raw Materials Key Suppliers Lists
 Table 182. Avian Influenza Vaccines Distributors List
 Table 183. Avian Influenza Vaccines Customers List
 Table 184. Avian Influenza Vaccines Market Trends
 Table 185. Avian Influenza Vaccines Market Drivers
 Table 186. Avian Influenza Vaccines Market Challenges
 Table 187. Avian Influenza Vaccines Market Restraints
 Table 188. Research Programs/Design for This Report
 Table 189. Key Data Information from Secondary Sources
 Table 190. Key Data Information from Primary Sources
 Table 191. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Avian Influenza Vaccines
 Figure 2. Global Avian Influenza Vaccines Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Avian Influenza Vaccines Market Share by Type: 2025 & 2032
 Figure 4. H5+H7 Avian Influenza Vaccines Product Picture
 Figure 5. H9 Avian Influenza Vaccines Product Picture
 Figure 6. Global Avian Influenza Vaccines Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Avian Influenza Vaccines Market Share by Application: 2025 & 2032
 Figure 8. Chicken
 Figure 9. Duck & Goose
 Figure 10. Other
 Figure 11. Global Avian Influenza Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Avian Influenza Vaccines Market Size (US$ Million), 2021–2032
 Figure 13. Global Avian Influenza Vaccines Sales (M Doses), 2021–2032
 Figure 14. Global Avian Influenza Vaccines Average Price (USD/K Doses), 2021–2032
 Figure 15. Avian Influenza Vaccines Report Years Considered
 Figure 16. Avian Influenza Vaccines Sales Share by Manufacturers in 2025
 Figure 17. Global Avian Influenza Vaccines Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Avian Influenza Vaccines Players: Market Share by Revenue in Avian Influenza Vaccines in 2025
 Figure 19. Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Avian Influenza Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Avian Influenza Vaccines Sales Market Share by Country (2021–2032)
 Figure 22. North America Avian Influenza Vaccines Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Avian Influenza Vaccines Sales Market Share by Country (2021–2032)
 Figure 26. Europe Avian Influenza Vaccines Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Avian Influenza Vaccines Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Avian Influenza Vaccines Revenue Market Share by Region (2021–2032)
 Figure 34. China Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Latin America Avian Influenza Vaccines Sales Market Share by Country (2021–2032)
 Figure 44. Latin America Avian Influenza Vaccines Revenue Market Share by Country (2021–2032)
 Figure 45. Mexico Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Brazil Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Argentina Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Avian Influenza Vaccines Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Avian Influenza Vaccines Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Avian Influenza Vaccines by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Avian Influenza Vaccines by Type (2021–2032)
 Figure 55. Global Avian Influenza Vaccines Price (USD/K Doses) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Avian Influenza Vaccines by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Avian Influenza Vaccines by Application (2021–2032)
 Figure 58. Global Avian Influenza Vaccines Price (USD/K Doses) by Application (2021–2032)
 Figure 59. Avian Influenza Vaccines Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc